These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18199718)

  • 21. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
    World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
    Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
    Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
    Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of MTHFR polymorphisms on methylation of MGMT in glioma patients from Northeast China with different folate levels.
    Liu N; Jiang J; Song YJ; Zhao SG; Tong ZG; Song HS; Wu H; Zhu JY; Gu YH; Sun Y; Hua W; Qi JP
    Genet Mol Res; 2013 Oct; 12(4):5160-71. PubMed ID: 24301776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
    Viswanathan M; Tsuchida N; Shanmugam G
    Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes.
    Supic G; Jovic N; Kozomara R; Zeljic K; Magic Z
    J Dent Res; 2011 Jan; 90(1):65-70. PubMed ID: 20940365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer.
    Oyama K; Kawakami K; Maeda K; Ishiguro K; Watanabe G
    Anticancer Res; 2004; 24(2B):649-54. PubMed ID: 15161007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status.
    Vasavi M; Ponnala S; Gujjari K; Boddu P; Bharatula RS; Prasad R; Ahuja YR; Hasan Q
    Tumori; 2006; 92(2):155-62. PubMed ID: 16724696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
    Ali AH; Kondo K; Namura T; Senba Y; Takizawa H; Nakagawa Y; Toba H; Kenzaki K; Sakiyama S; Tangoku A
    Mol Carcinog; 2011 Feb; 50(2):89-99. PubMed ID: 21229606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
    Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers.
    Wu F; Liu J; Qiu YL; Wang W; Zhu SM; Sun P; Miao WB; Li YL; Brandt-Rauf PW; Xia ZL
    Int J Occup Med Environ Health; 2013 Mar; 26(1):173-82. PubMed ID: 23412991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
    Löf-Ohlin ZM; Nilsson TK
    Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
    Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylation pattern of DNA repair genes and microsatellite instability in hepatocelluar carcinoma].
    Park JH; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Lee JH; Kim SJ
    Korean J Gastroenterol; 2006 Nov; 48(5):327-36. PubMed ID: 17132921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
    Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.